Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $19.17.
Several equities research analysts recently issued reports on CCAP shares. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price target on the stock. Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. Keefe, Bruyette & Woods lifted their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday. Finally, Bank of America decreased their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 15th.
View Our Latest Stock Analysis on Crescent Capital BDC
Crescent Capital BDC Trading Down 0.2 %
Crescent Capital BDC Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a yield of 8.76%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 65.88%.
Institutional Investors Weigh In On Crescent Capital BDC
Several hedge funds have recently added to or reduced their stakes in CCAP. Alpine Global Management LLC acquired a new stake in Crescent Capital BDC during the 1st quarter worth approximately $217,000. Confluence Investment Management LLC lifted its position in shares of Crescent Capital BDC by 3.0% in the 2nd quarter. Confluence Investment Management LLC now owns 71,623 shares of the company’s stock worth $1,345,000 after purchasing an additional 2,108 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its position in shares of Crescent Capital BDC by 14.1% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock worth $1,517,000 after purchasing an additional 10,000 shares during the period. Hennion & Walsh Asset Management Inc. lifted its position in shares of Crescent Capital BDC by 182.3% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 49,482 shares of the company’s stock worth $929,000 after purchasing an additional 31,952 shares during the period. Finally, Catalina Capital Group LLC acquired a new position in shares of Crescent Capital BDC in the 2nd quarter worth approximately $220,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- 3 Small Caps With Big Return Potential
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Is WallStreetBets and What Stocks Are They Targeting?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Insider Buying Explained: What Investors Need to Know
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.